Mariper (Perindopril Tert-Butylamine)

Perindopril blocks the angiotensin‑converting enzyme, which stops the formation of angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, blood vessels dilate, aldosterone secretion falls, and sodium and water retention decrease, leading to lower blood pressure and reduced strain on the heart.

The appropriate dose of Mariper is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and renal function. Dosage adjustments are made individually; patients should follow the specific instructions provided by their healthcare professional.

Mariper is classified as pregnancy category D, indicating evidence of fetal risk and it should be avoided in pregnancy. It is also not recommended while breastfeeding because the drug can pass into breast milk and may affect the infant.

To request Mariper, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mariper (perindopril) shares the core mechanism of ACE inhibition with other drugs in the class, such as enalapril or lisinopril. Differences may lie in pharmacokinetic profiles, dosing frequency, and specific clinical trial data supporting cardiovascular outcomes, but efficacy in lowering blood pressure is comparable across the class.

Mariper should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Mariper is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but patients should follow the timing and any specific instructions given by their prescriber to ensure consistent absorption.

The most serious adverse events include angioedema, which can cause airway obstruction, severe hypotension leading to fainting, acute renal failure, and significant hyperkalaemia. Patients should seek immediate medical attention if they experience swelling of the face or throat, sudden dizziness, or reduced urine output.

Mariper is contraindicated in patients with a known hypersensitivity to perindopril or any ACE inhibitor, those with a history of angioedema related to ACE inhibition, and pregnant women. Caution is also advised for individuals with severe renal impairment or high potassium levels.